The phase 3b SOUL trial (NCT03914326) randomly assigned 9,650 patients of at least 50 years of age with type 2 diabetes and atherosclerotic vascular disease and/or chronic kidney disease 1:1 to oral semaglutide plus standard-of-care or a placebo plus standard-of-care
GLP-1 Match Score No membership fees Friendly, responsive customer support Pricing can be confusing compared to other providers Not available in MS, CA, or AL
Dose adjustment, or titration, is a critical part of the process
NHS Treatment Schedule and Dosing for B12 Injections The NHS follows evidence-based protocols for B12 replacement therapy in pernicious anaemia, with treatment divided into two phases: loading (induction) and maintenance
As the active ingredients are slightly different, you may find that one treatment is better for you or that one causes fewer side effects